Answer
The most common adverse effects of regadenoson in clinical development were dyspnoea (29%), headache (27%), flushing (23%), chest pain (19%), electrocardiogram ST segment changes (18%), gastrointestinal discomfort (15%) and dizziness (11%).
Sources for this answer
- Rapiscan 400 microgram solution for injectionGE Healthcare Limited · emc · SmPC §4.8 Undesirable effects · Version 3Document updated
Sources checked